Justin Lin

ALS is a neurodegenerative disease that results in death 3-5 years following diagnosis. Currently, there is no cure or definitive diagnostic test for ALS. Eighteen-year-old Lin’s project investigates two novel techniques: firstly, we demonstrate the potential of our modified ELISA technique as a diagnostic tool. We also show our TAT-CT4-CTM peptide’s ability to knock down ALS-associated misfolded SOD1; this peptide could be a cure for ALS.